LayerRx Mapping ID
240
Slot System
Featured Buckets
Featured Buckets Admin
Medscape Lead Concept
8

Riehl Melanosis in a 27-Year-Old Bahraini Woman

Article Type
Changed
Thu, 01/10/2019 - 12:41
Display Headline
Riehl Melanosis in a 27-Year-Old Bahraini Woman

Article PDF
Author and Disclosure Information

Nagaraj V, Jaffar H, Ansari N

Issue
Cutis - 81(3)
Publications
Topics
Page Number
145-148
Legacy Keywords
Riehl Melanosis, hyperpigmentation, hyperplasia, hyperactivity, dermatosis, pigmented contact dermatitis, pruritus, cosmetics, photocontact dermatitis, Nagaraj V, Jaffar H, Ansari NRiehl Melanosis, hyperpigmentation, hyperplasia, hyperactivity, dermatosis, pigmented contact dermatitis, pruritus, cosmetics, photocontact dermatitis, Nagaraj V, Jaffar H, Ansari N
Sections
Author and Disclosure Information

Nagaraj V, Jaffar H, Ansari N

Author and Disclosure Information

Nagaraj V, Jaffar H, Ansari N

Article PDF
Article PDF

Issue
Cutis - 81(3)
Issue
Cutis - 81(3)
Page Number
145-148
Page Number
145-148
Publications
Publications
Topics
Article Type
Display Headline
Riehl Melanosis in a 27-Year-Old Bahraini Woman
Display Headline
Riehl Melanosis in a 27-Year-Old Bahraini Woman
Legacy Keywords
Riehl Melanosis, hyperpigmentation, hyperplasia, hyperactivity, dermatosis, pigmented contact dermatitis, pruritus, cosmetics, photocontact dermatitis, Nagaraj V, Jaffar H, Ansari NRiehl Melanosis, hyperpigmentation, hyperplasia, hyperactivity, dermatosis, pigmented contact dermatitis, pruritus, cosmetics, photocontact dermatitis, Nagaraj V, Jaffar H, Ansari N
Legacy Keywords
Riehl Melanosis, hyperpigmentation, hyperplasia, hyperactivity, dermatosis, pigmented contact dermatitis, pruritus, cosmetics, photocontact dermatitis, Nagaraj V, Jaffar H, Ansari NRiehl Melanosis, hyperpigmentation, hyperplasia, hyperactivity, dermatosis, pigmented contact dermatitis, pruritus, cosmetics, photocontact dermatitis, Nagaraj V, Jaffar H, Ansari N
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Phytophotodermatitis: Case Report and Review of the Literature

Article Type
Changed
Thu, 01/10/2019 - 12:41
Display Headline
Phytophotodermatitis: Case Report and Review of the Literature

Article PDF
Author and Disclosure Information

Janda PH, Bhambri S, Del Rosso JQ, Mobini N

Issue
Cutis - 81(2)
Publications
Topics
Page Number
99-103
Legacy Keywords
Phytophotodermatitis, phototoxic, dermal reaction, photochemistry, Rutaceae, Umbelliferae, Janda PH, Bhambri S, Del Rosso JQ, Mobini NPhytophotodermatitis, phototoxic, dermal reaction, photochemistry, Rutaceae, Umbelliferae, Janda PH, Bhambri S, Del Rosso JQ, Mobini N
Sections
Author and Disclosure Information

Janda PH, Bhambri S, Del Rosso JQ, Mobini N

Author and Disclosure Information

Janda PH, Bhambri S, Del Rosso JQ, Mobini N

Article PDF
Article PDF

Issue
Cutis - 81(2)
Issue
Cutis - 81(2)
Page Number
99-103
Page Number
99-103
Publications
Publications
Topics
Article Type
Display Headline
Phytophotodermatitis: Case Report and Review of the Literature
Display Headline
Phytophotodermatitis: Case Report and Review of the Literature
Legacy Keywords
Phytophotodermatitis, phototoxic, dermal reaction, photochemistry, Rutaceae, Umbelliferae, Janda PH, Bhambri S, Del Rosso JQ, Mobini NPhytophotodermatitis, phototoxic, dermal reaction, photochemistry, Rutaceae, Umbelliferae, Janda PH, Bhambri S, Del Rosso JQ, Mobini N
Legacy Keywords
Phytophotodermatitis, phototoxic, dermal reaction, photochemistry, Rutaceae, Umbelliferae, Janda PH, Bhambri S, Del Rosso JQ, Mobini NPhytophotodermatitis, phototoxic, dermal reaction, photochemistry, Rutaceae, Umbelliferae, Janda PH, Bhambri S, Del Rosso JQ, Mobini N
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Kyrle's Disease

Article Type
Changed
Thu, 01/10/2019 - 12:41
Display Headline
Kyrle's Disease

Article PDF
Author and Disclosure Information

Bhambri S, Del Rosso JQ, Mobini N, Janda P

Issue
Cutis - 81(1)
Publications
Topics
Page Number
26-28
Legacy Keywords
Kyrle's disease, hyperkeratosis, dermatosis, atrophic epidermis, papillary dermis, renal failure, Bhambri S, Del Rosso JQ, Mobini N, Janda PKyrle's disease, hyperkeratosis, dermatosis, atrophic epidermis, papillary dermis, renal failure, Bhambri S, Del Rosso JQ, Mobini N, Janda P
Sections
Author and Disclosure Information

Bhambri S, Del Rosso JQ, Mobini N, Janda P

Author and Disclosure Information

Bhambri S, Del Rosso JQ, Mobini N, Janda P

Article PDF
Article PDF

Issue
Cutis - 81(1)
Issue
Cutis - 81(1)
Page Number
26-28
Page Number
26-28
Publications
Publications
Topics
Article Type
Display Headline
Kyrle's Disease
Display Headline
Kyrle's Disease
Legacy Keywords
Kyrle's disease, hyperkeratosis, dermatosis, atrophic epidermis, papillary dermis, renal failure, Bhambri S, Del Rosso JQ, Mobini N, Janda PKyrle's disease, hyperkeratosis, dermatosis, atrophic epidermis, papillary dermis, renal failure, Bhambri S, Del Rosso JQ, Mobini N, Janda P
Legacy Keywords
Kyrle's disease, hyperkeratosis, dermatosis, atrophic epidermis, papillary dermis, renal failure, Bhambri S, Del Rosso JQ, Mobini N, Janda PKyrle's disease, hyperkeratosis, dermatosis, atrophic epidermis, papillary dermis, renal failure, Bhambri S, Del Rosso JQ, Mobini N, Janda P
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Updated Review of Minimally Invasive Treatments

Article Type
Changed
Thu, 01/10/2019 - 12:13
Display Headline
Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Updated Review of Minimally Invasive Treatments

Article PDF
Author and Disclosure Information

Mitropoulos P, Norman R

Issue
Cutis - 81(1)
Publications
Topics
Page Number
53-60
Author and Disclosure Information

Mitropoulos P, Norman R

Author and Disclosure Information

Mitropoulos P, Norman R

Article PDF
Article PDF

Issue
Cutis - 81(1)
Issue
Cutis - 81(1)
Page Number
53-60
Page Number
53-60
Publications
Publications
Topics
Article Type
Display Headline
Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Updated Review of Minimally Invasive Treatments
Display Headline
Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Updated Review of Minimally Invasive Treatments
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Brachioradial Pruritus: A Case Report and Review of the Literature

Article Type
Changed
Thu, 01/10/2019 - 12:13
Display Headline
Brachioradial Pruritus: A Case Report and Review of the Literature

Brachioradial pruritus is an enigmatic entity characterized by pruritus localized to the skin overlying the proximal heads of the brachioradialis muscle, with few other clinical symptoms.1-5 It was first described by Waisman6 in 1968. Brachioradial pruritus characteristically affects middle-aged women residing in tropical to temperate climates, though it may occur in males and individuals residing in other climates.1-8 It often presents as tingling, burning pruritus on the dorsal aspect of the forearm. Pruritus may be unilateral or bilateral and may extend up the arm and across the upper back. It often is described as burning, stinging, or painful, and is seasonal in nature, often presenting in late summer and lasting into December.1-5 Brachioradial pruritus was originally associated with solar exposure and UV radiation. Later, Heyl9 proposed that cervical nerve root impingement or injury secondary to cervical trauma was causative. Although a true cause remains elusive, both actinic damage and cervical spine disease are likely involved. We discuss an otherwise healthy woman who presented with nonspecific pruritus consistent with brachioradial pruritus.


Case Report
A 46-year-old woman presented with persistent pruritus of the left proximal lateral forearm. The pruritus had been present for several years and was recalcitrant to a multitude of therapeutic modalities, including topical corticosteroids and oral antihistamines. Application of heat did not affect her symptoms; however, application of cold compresses did alleviate some of the pruritus. Her medical history was noncontributory. Her surgical history was pertinent for prior anterior cervical discectomy and fusion from C4 to C6. Physical examination revealed no obvious cutaneous lesions in the site other than mild erythema secondary to scratching. Magnetic resonance imaging of her cervical spine revealed a left-sided osteophyte causing minimal left neural foraminal stenosis at the level of C3 to C4 (Figure). Electromyography and nerve conduction velocity studies of the left upper extremity revealed a mildly prolonged left median sensory latency. The patient was treated with topical capsaicin cream with moderate success. She also was advised to avoid sun exposure to the affected area.

Comment
Brachioradial pruritus affects a focal circumscribed area of the proximal lateral forearm. The area typically involves a sun-exposed region and may include the forearm, arm, shoulder, neck, and/or upper thorax.2 Middle-aged women are most commonly affected, with tingling, burning, and pruritus of the affected area.1 Symptoms may last from August to December and may subside during the winter.1-5 Pruritus may be unilateral or bilateral. The nature of the pruritus is often described as burning, stinging, or painful, and manifests a seasonal relation, with high incidence in late summer corresponding with the highest UV exposure.1 Patients may report intensification of pruritus with scratching, which may be related to damage of peripheral nerve fibers.2,10 This intensification may, in part, be secondary to chronic UVA irradiation.11 Involvement of C fibers containing neuropeptides responsible for pruritus explains the rationale for treatment with topical capsaicin.2,5 Application of ice often is the only means of alleviating pruritus.10,12 The consistency of relief with ice is useful in the diagnostic screening of this entity.10 The neurophysiology of pruritus is not fully understood. However, it is known that Aδ and C fibers are responsible for the transmission of pruritus.9 Pruritus can be categorized as pruritoceptive (originating in the skin) or neurogenic (originating in the central nervous system), or a combination of both. The Aδ and C fibers are co-responsive to temperature change as well as pruritus. Increases in skin temperature lower the threshold of cutaneous pruritus receptor units.13 The neural pathway for pruritus has been established. Nociceptor C fibers transmit impulses to the dorsal horn of the spinal cord and then to the thalamus via the spinothalamic tract.14 Scratching typically relieves the sensation of pruritus.15 The gate-control theory postulates that afferent sensory input from cutaneous C fibers is modulated by a gate-control system at the level of the spinal cord.5,16,17 A subsequent Aδ impulse may act in a negative feedback method to shut off C-fiber stimulation. However, stimulation of Aδ fibers in brachioradial pruritus paradoxically seems to potentiate the sensation of pruritus.5 Wallengren5 suggested that local damage to peripheral nerve fibers could be responsible for this potentiation of pruritic sensation. Kumakiri et al18 demonstrated ultrastructural damage to dermal nerve fibers following UVA irradiation. UV radiation has been shown to cause a sensitizing effect on sensory nerve fibers and lower the threshold for sensory nerve stimulation, which may occur via direct effects of UV exposure or by release of neural mediators.19 The pathophysiology of brachioradial pruritus is controversial. The 2 proposed associations are UV exposure and cervical spine disease.20 Wallengren and Sundler2 proposed that solar-induced nerve injury is responsible for brachioradial pruritus. UV radiation may be an eliciting factor, while cervical spine disease may be a predisposing factor.2 On the contrary, Fisher21 reported on the association of cervical nerve root impingement and involvement of 1 or more of the C5 to C8 cervical nerve root segments. Brachioradial pruritus has been reported in association with an ependymoma and secondary to cervical nerve compression.9,22 In a report by Heyl,9 4 of 14 patients demonstrated evidence of degenerative changes and osteoarthritis between C4 and C7. In addition, Heyl9 noted that brachioradial pruritus may be caused by compression of structures not identified by cervical radiographs. In a series of 11 patients with brachioradial pruritus who underwent radiography of the spine, Goodkin et al12 found that all patients demonstrated radiographic abnormalities of the cervical spine. Magnetic resonance imaging is the most reliable diagnostic method for cervical nerve root compression.20,22 Recently, Crevits20 suggested that neural damage from peripheral nerves by solar radiation or local injury or from central sensory pathways, such as cervical spine disease, is a nonspecific cause. In view of the literature, a definitive pathophysiology for brachioradial pruritus does not exist. It is clear that it is a unique clinical entity, but the pathophysiologic basis is not known. While the association between cervical spine disease and brachioradial pruritus is not fully understood, the prevalence of cervical spine disease is higher in patients with brachioradial pruritus.12 It has not been determined if this association is causal or causative.20 A similar localized itch syndrome, notalgia paresthetica (NP), also has been examined with respect to cervical spine pathology.12,23-25 NP is similar to brachioradial pruritus but involves the dorsal spinal nerves. Savk et al23 found the presence of vertebral column pathology in 7 of 10 patients with NP. A subsequent larger study involving 43 patients with NP reported that in 34 patients (79%), spinal pathology had been detected by radiographs. Additionally, in 65% of patients (28/43), changes were most prominent in the vertebrae and corresponded to clinically involved dermatomes.24 However, not all pathologies are detectable via radiographic imaging.25 Thus, Savk and Savk25 reinforced the necessity of clinical and radiographic examination. Histologic examination is not necessary for the clinical diagnosis of brachioradial pruritus. Cutaneous biopsies most often demonstrate nonspecific findings and/or chronic solar damage. Wallengren and Sundler2 compared cutaneous biopsies in afflicted and control patients utilizing antibodies against a pan-neuronal marker, protein gene product 9.5, calcitonin gene-related peptide, and vanilloid receptor subtype 1 (VR1) for capsaicin-sensitive nerve structures. The number of protein gene product 9.5 immunoreative nerve fibers was reduced in pruritic skin by 23% to 43%.2 These findings suggest that brachioradial pruritus may be elicited by exposure to UV radiation and/or heat. Wallengren and Sundler2 noted one patient who relapsed with pruritus during the winter following use of a heating pad to relieve neck pain, which supports the notion that UV radiation and/or heat may be causative. Immunohistochemical studies demonstrated protein gene product 9.5 immunoreactive nerve fibers in a dense population in the epidermis and the dermis and calcitonin gene-related peptide immunoreactive nerve fibers located primarily in the dermis. Capsaicin-sensitive VR1 immunoreactive nerve fibers were located as free nerve fibers.2 Wallengren and Sundler2 proposed that the VR1 structures are associated with thermoreception. The reduction in nerve fibers via all markers in patients with brachioradial pruritus implicates their role. Furthermore, these histologic changes resemble those found in patients after serial phototherapy.2,26 Underlying cervical spine disease may amplify this pruritus. Treatment of brachioradial pruritus includes a multitude of possible topical and oral modalities, such as topical capsaicin, gabapentin, carbamazepine, oxcarbamazepine, cervical spine manipulation, anti-inflammatory medications, surgical rib resection, avoidance of sun exposure, and lamotrigine.1,3,5,12,20,21,27-32 Pruritus is a common symptom with a multitude of potential causes, some of which are never diagnosed. The absence of cutaneous signs makes diagnosis more difficult; however, the consistency of anatomic location and historical characteristics make the diagnosis of brachioradial pruritus possible. In addition, relief of pruritus with application of ice helps to confirm the diagnosis.10 A familial form of brachioradial pruritus was reported with a dominant and possible X-linked inheritance pattern.33 While an association between brachioradial pruritus and cervical spine disease is present, cervical spine disease alone cannot explain the pathophysiology of brachioradial pruritus. Furthermore, cervical spine disease undetectable by radiography may hinder a definitive understanding of this association. It is likely that both UV exposure and cervical spine disease contribute to this entity.

References

  1. Veien NK, Hattel T, Laurberg G, et al. Brachioradial pruritus. J Am Acad Dermatol. 2001;44:704-705.
  2. Wallengren J, Sundler F. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during symptom-free remissions. J Am Acad Dermatol. 2005;52:142-145.
  3. Barry R, Rogers S. Brachioradial pruritus—an enigmatic entity. Clin Exp Dermatol. 2004;29:637-638.
  4. Cohen AD, Masalha R, Medvedovsky E, et al. Brachioradial pruritus: a symptom of neuropathy. J Am Acad Dermatol. 2003;48:825-828.
  5. Wallengren J. Brachioradial pruritus: a recurrent solar dermopathy. J Am Acad Dermatol. 1998;39(5, pt 1):803-806
  6. Waisman M. Solar pruritus of the elbows (brachioradial summer pruritus). Arch Dermatol. 1968;98:481-485.
  7. Knight TE, Hayashi T. Solar (brachioradial) pruritus—response to capsaicin cream. Int J Dermatol. 1994;33:206-209.
  8. Walcyk PJ, Elpern DJ. Brachioradial pruritus: a tropical dermopathy. Br J Dermatol. 1986;115:177-180.
  9. Heyl T. Brachioradial pruritus. Arch Dermatol. 1983;119:115-116.
  10. Bernhard JD, Bordeaux JS. Medical pearl: the ice-pack sign in brachioradial pruritus. J Am Acad Dermatol. 2005;52:1073.
  11. Gilchrest BA, Soter NA, Hawk JL, et al. Histologic changes associated with ultraviolet A–induced erythema in normal human skin. J Am Acad Dermatol. 1983;9:213-219.
  12. Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic pruritus. J Am Acad Dermatol. 2003;48:521-524.
  13. Fruhstorfer H, Hermanns M, Latzke L. The effects of thermal stimulation on clinical and experimental itch. Pain. 1986;24:259-269.
  14. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96:7-26.
  15. Wallengren J. The pathophysiology of itch. Eur J Dermatol. 1993;3:643-647.
  16. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
  17. Teofoli P, Procacci P, Maresca M, et al. Itch and pain. Int J Dermatol. 1996;35:159-166.
  18. Kumakiri M, Hashimoto K, Willis I. Biological changes of human cutaneous nerves caused by ultraviolet irradiation: an ultrastructural study. Br J Dermatol. 1978;99:65-75.
  19. Legat FJ, Wolf P. Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin? Photochem Photobiol Sci. 2006;5:170-176.
  20. Crevits L. Brachioradial pruritus—a peculiar neuropathic disorder. Clin Neurol Neurosurg. 2006;108:803-805.
  21. Fisher DA. Brachioradial pruritus wanted: a sure cause (and cure) for brachioradial pruritus. Int J Dermatol. 1997;36:817-818.
  22. Kavak A, Dosoglu M. Can a spinal cord tumor cause brachioradial pruritus? J Am Acad Dermatol. 2002;46:437-440.
  23. Savk E, Savk O, Bolukbasi O, et al. Notalgia paresthetica: a study on pathogenesis. Int J Dermatol. 2000;39:754-759.
  24. Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol. 2005;52:1085-1087.
  25. Savk E, Savk SO. On brachioradial pruritus and notalgia paresthetica. J Am Acad Dermatol. 20
Article PDF
Author and Disclosure Information

Drs. Lane and Spiegel and Mr. McKenzie report no conflict of interest. The authors report no discussion of off-label use. From Mercer University School of Medicine, Macon, Georgia. Dr. Lane is Clinical Assistant Professor, Departments of Surgery and Internal Medicine (Dermatology); Mr. McKenzie is a medical student; and Dr. Spiegel is Clinical Assistant Professor, Department of Internal Medicine (Neurology).

Joshua E. Lane, MD; Joshua T. McKenzie, BS; John Spiegel, MD

Issue
Cutis - 81(1)
Publications
Topics
Page Number
37-40
Author and Disclosure Information

Drs. Lane and Spiegel and Mr. McKenzie report no conflict of interest. The authors report no discussion of off-label use. From Mercer University School of Medicine, Macon, Georgia. Dr. Lane is Clinical Assistant Professor, Departments of Surgery and Internal Medicine (Dermatology); Mr. McKenzie is a medical student; and Dr. Spiegel is Clinical Assistant Professor, Department of Internal Medicine (Neurology).

Joshua E. Lane, MD; Joshua T. McKenzie, BS; John Spiegel, MD

Author and Disclosure Information

Drs. Lane and Spiegel and Mr. McKenzie report no conflict of interest. The authors report no discussion of off-label use. From Mercer University School of Medicine, Macon, Georgia. Dr. Lane is Clinical Assistant Professor, Departments of Surgery and Internal Medicine (Dermatology); Mr. McKenzie is a medical student; and Dr. Spiegel is Clinical Assistant Professor, Department of Internal Medicine (Neurology).

Joshua E. Lane, MD; Joshua T. McKenzie, BS; John Spiegel, MD

Article PDF
Article PDF

Brachioradial pruritus is an enigmatic entity characterized by pruritus localized to the skin overlying the proximal heads of the brachioradialis muscle, with few other clinical symptoms.1-5 It was first described by Waisman6 in 1968. Brachioradial pruritus characteristically affects middle-aged women residing in tropical to temperate climates, though it may occur in males and individuals residing in other climates.1-8 It often presents as tingling, burning pruritus on the dorsal aspect of the forearm. Pruritus may be unilateral or bilateral and may extend up the arm and across the upper back. It often is described as burning, stinging, or painful, and is seasonal in nature, often presenting in late summer and lasting into December.1-5 Brachioradial pruritus was originally associated with solar exposure and UV radiation. Later, Heyl9 proposed that cervical nerve root impingement or injury secondary to cervical trauma was causative. Although a true cause remains elusive, both actinic damage and cervical spine disease are likely involved. We discuss an otherwise healthy woman who presented with nonspecific pruritus consistent with brachioradial pruritus.


Case Report
A 46-year-old woman presented with persistent pruritus of the left proximal lateral forearm. The pruritus had been present for several years and was recalcitrant to a multitude of therapeutic modalities, including topical corticosteroids and oral antihistamines. Application of heat did not affect her symptoms; however, application of cold compresses did alleviate some of the pruritus. Her medical history was noncontributory. Her surgical history was pertinent for prior anterior cervical discectomy and fusion from C4 to C6. Physical examination revealed no obvious cutaneous lesions in the site other than mild erythema secondary to scratching. Magnetic resonance imaging of her cervical spine revealed a left-sided osteophyte causing minimal left neural foraminal stenosis at the level of C3 to C4 (Figure). Electromyography and nerve conduction velocity studies of the left upper extremity revealed a mildly prolonged left median sensory latency. The patient was treated with topical capsaicin cream with moderate success. She also was advised to avoid sun exposure to the affected area.

Comment
Brachioradial pruritus affects a focal circumscribed area of the proximal lateral forearm. The area typically involves a sun-exposed region and may include the forearm, arm, shoulder, neck, and/or upper thorax.2 Middle-aged women are most commonly affected, with tingling, burning, and pruritus of the affected area.1 Symptoms may last from August to December and may subside during the winter.1-5 Pruritus may be unilateral or bilateral. The nature of the pruritus is often described as burning, stinging, or painful, and manifests a seasonal relation, with high incidence in late summer corresponding with the highest UV exposure.1 Patients may report intensification of pruritus with scratching, which may be related to damage of peripheral nerve fibers.2,10 This intensification may, in part, be secondary to chronic UVA irradiation.11 Involvement of C fibers containing neuropeptides responsible for pruritus explains the rationale for treatment with topical capsaicin.2,5 Application of ice often is the only means of alleviating pruritus.10,12 The consistency of relief with ice is useful in the diagnostic screening of this entity.10 The neurophysiology of pruritus is not fully understood. However, it is known that Aδ and C fibers are responsible for the transmission of pruritus.9 Pruritus can be categorized as pruritoceptive (originating in the skin) or neurogenic (originating in the central nervous system), or a combination of both. The Aδ and C fibers are co-responsive to temperature change as well as pruritus. Increases in skin temperature lower the threshold of cutaneous pruritus receptor units.13 The neural pathway for pruritus has been established. Nociceptor C fibers transmit impulses to the dorsal horn of the spinal cord and then to the thalamus via the spinothalamic tract.14 Scratching typically relieves the sensation of pruritus.15 The gate-control theory postulates that afferent sensory input from cutaneous C fibers is modulated by a gate-control system at the level of the spinal cord.5,16,17 A subsequent Aδ impulse may act in a negative feedback method to shut off C-fiber stimulation. However, stimulation of Aδ fibers in brachioradial pruritus paradoxically seems to potentiate the sensation of pruritus.5 Wallengren5 suggested that local damage to peripheral nerve fibers could be responsible for this potentiation of pruritic sensation. Kumakiri et al18 demonstrated ultrastructural damage to dermal nerve fibers following UVA irradiation. UV radiation has been shown to cause a sensitizing effect on sensory nerve fibers and lower the threshold for sensory nerve stimulation, which may occur via direct effects of UV exposure or by release of neural mediators.19 The pathophysiology of brachioradial pruritus is controversial. The 2 proposed associations are UV exposure and cervical spine disease.20 Wallengren and Sundler2 proposed that solar-induced nerve injury is responsible for brachioradial pruritus. UV radiation may be an eliciting factor, while cervical spine disease may be a predisposing factor.2 On the contrary, Fisher21 reported on the association of cervical nerve root impingement and involvement of 1 or more of the C5 to C8 cervical nerve root segments. Brachioradial pruritus has been reported in association with an ependymoma and secondary to cervical nerve compression.9,22 In a report by Heyl,9 4 of 14 patients demonstrated evidence of degenerative changes and osteoarthritis between C4 and C7. In addition, Heyl9 noted that brachioradial pruritus may be caused by compression of structures not identified by cervical radiographs. In a series of 11 patients with brachioradial pruritus who underwent radiography of the spine, Goodkin et al12 found that all patients demonstrated radiographic abnormalities of the cervical spine. Magnetic resonance imaging is the most reliable diagnostic method for cervical nerve root compression.20,22 Recently, Crevits20 suggested that neural damage from peripheral nerves by solar radiation or local injury or from central sensory pathways, such as cervical spine disease, is a nonspecific cause. In view of the literature, a definitive pathophysiology for brachioradial pruritus does not exist. It is clear that it is a unique clinical entity, but the pathophysiologic basis is not known. While the association between cervical spine disease and brachioradial pruritus is not fully understood, the prevalence of cervical spine disease is higher in patients with brachioradial pruritus.12 It has not been determined if this association is causal or causative.20 A similar localized itch syndrome, notalgia paresthetica (NP), also has been examined with respect to cervical spine pathology.12,23-25 NP is similar to brachioradial pruritus but involves the dorsal spinal nerves. Savk et al23 found the presence of vertebral column pathology in 7 of 10 patients with NP. A subsequent larger study involving 43 patients with NP reported that in 34 patients (79%), spinal pathology had been detected by radiographs. Additionally, in 65% of patients (28/43), changes were most prominent in the vertebrae and corresponded to clinically involved dermatomes.24 However, not all pathologies are detectable via radiographic imaging.25 Thus, Savk and Savk25 reinforced the necessity of clinical and radiographic examination. Histologic examination is not necessary for the clinical diagnosis of brachioradial pruritus. Cutaneous biopsies most often demonstrate nonspecific findings and/or chronic solar damage. Wallengren and Sundler2 compared cutaneous biopsies in afflicted and control patients utilizing antibodies against a pan-neuronal marker, protein gene product 9.5, calcitonin gene-related peptide, and vanilloid receptor subtype 1 (VR1) for capsaicin-sensitive nerve structures. The number of protein gene product 9.5 immunoreative nerve fibers was reduced in pruritic skin by 23% to 43%.2 These findings suggest that brachioradial pruritus may be elicited by exposure to UV radiation and/or heat. Wallengren and Sundler2 noted one patient who relapsed with pruritus during the winter following use of a heating pad to relieve neck pain, which supports the notion that UV radiation and/or heat may be causative. Immunohistochemical studies demonstrated protein gene product 9.5 immunoreactive nerve fibers in a dense population in the epidermis and the dermis and calcitonin gene-related peptide immunoreactive nerve fibers located primarily in the dermis. Capsaicin-sensitive VR1 immunoreactive nerve fibers were located as free nerve fibers.2 Wallengren and Sundler2 proposed that the VR1 structures are associated with thermoreception. The reduction in nerve fibers via all markers in patients with brachioradial pruritus implicates their role. Furthermore, these histologic changes resemble those found in patients after serial phototherapy.2,26 Underlying cervical spine disease may amplify this pruritus. Treatment of brachioradial pruritus includes a multitude of possible topical and oral modalities, such as topical capsaicin, gabapentin, carbamazepine, oxcarbamazepine, cervical spine manipulation, anti-inflammatory medications, surgical rib resection, avoidance of sun exposure, and lamotrigine.1,3,5,12,20,21,27-32 Pruritus is a common symptom with a multitude of potential causes, some of which are never diagnosed. The absence of cutaneous signs makes diagnosis more difficult; however, the consistency of anatomic location and historical characteristics make the diagnosis of brachioradial pruritus possible. In addition, relief of pruritus with application of ice helps to confirm the diagnosis.10 A familial form of brachioradial pruritus was reported with a dominant and possible X-linked inheritance pattern.33 While an association between brachioradial pruritus and cervical spine disease is present, cervical spine disease alone cannot explain the pathophysiology of brachioradial pruritus. Furthermore, cervical spine disease undetectable by radiography may hinder a definitive understanding of this association. It is likely that both UV exposure and cervical spine disease contribute to this entity.

Brachioradial pruritus is an enigmatic entity characterized by pruritus localized to the skin overlying the proximal heads of the brachioradialis muscle, with few other clinical symptoms.1-5 It was first described by Waisman6 in 1968. Brachioradial pruritus characteristically affects middle-aged women residing in tropical to temperate climates, though it may occur in males and individuals residing in other climates.1-8 It often presents as tingling, burning pruritus on the dorsal aspect of the forearm. Pruritus may be unilateral or bilateral and may extend up the arm and across the upper back. It often is described as burning, stinging, or painful, and is seasonal in nature, often presenting in late summer and lasting into December.1-5 Brachioradial pruritus was originally associated with solar exposure and UV radiation. Later, Heyl9 proposed that cervical nerve root impingement or injury secondary to cervical trauma was causative. Although a true cause remains elusive, both actinic damage and cervical spine disease are likely involved. We discuss an otherwise healthy woman who presented with nonspecific pruritus consistent with brachioradial pruritus.


Case Report
A 46-year-old woman presented with persistent pruritus of the left proximal lateral forearm. The pruritus had been present for several years and was recalcitrant to a multitude of therapeutic modalities, including topical corticosteroids and oral antihistamines. Application of heat did not affect her symptoms; however, application of cold compresses did alleviate some of the pruritus. Her medical history was noncontributory. Her surgical history was pertinent for prior anterior cervical discectomy and fusion from C4 to C6. Physical examination revealed no obvious cutaneous lesions in the site other than mild erythema secondary to scratching. Magnetic resonance imaging of her cervical spine revealed a left-sided osteophyte causing minimal left neural foraminal stenosis at the level of C3 to C4 (Figure). Electromyography and nerve conduction velocity studies of the left upper extremity revealed a mildly prolonged left median sensory latency. The patient was treated with topical capsaicin cream with moderate success. She also was advised to avoid sun exposure to the affected area.

Comment
Brachioradial pruritus affects a focal circumscribed area of the proximal lateral forearm. The area typically involves a sun-exposed region and may include the forearm, arm, shoulder, neck, and/or upper thorax.2 Middle-aged women are most commonly affected, with tingling, burning, and pruritus of the affected area.1 Symptoms may last from August to December and may subside during the winter.1-5 Pruritus may be unilateral or bilateral. The nature of the pruritus is often described as burning, stinging, or painful, and manifests a seasonal relation, with high incidence in late summer corresponding with the highest UV exposure.1 Patients may report intensification of pruritus with scratching, which may be related to damage of peripheral nerve fibers.2,10 This intensification may, in part, be secondary to chronic UVA irradiation.11 Involvement of C fibers containing neuropeptides responsible for pruritus explains the rationale for treatment with topical capsaicin.2,5 Application of ice often is the only means of alleviating pruritus.10,12 The consistency of relief with ice is useful in the diagnostic screening of this entity.10 The neurophysiology of pruritus is not fully understood. However, it is known that Aδ and C fibers are responsible for the transmission of pruritus.9 Pruritus can be categorized as pruritoceptive (originating in the skin) or neurogenic (originating in the central nervous system), or a combination of both. The Aδ and C fibers are co-responsive to temperature change as well as pruritus. Increases in skin temperature lower the threshold of cutaneous pruritus receptor units.13 The neural pathway for pruritus has been established. Nociceptor C fibers transmit impulses to the dorsal horn of the spinal cord and then to the thalamus via the spinothalamic tract.14 Scratching typically relieves the sensation of pruritus.15 The gate-control theory postulates that afferent sensory input from cutaneous C fibers is modulated by a gate-control system at the level of the spinal cord.5,16,17 A subsequent Aδ impulse may act in a negative feedback method to shut off C-fiber stimulation. However, stimulation of Aδ fibers in brachioradial pruritus paradoxically seems to potentiate the sensation of pruritus.5 Wallengren5 suggested that local damage to peripheral nerve fibers could be responsible for this potentiation of pruritic sensation. Kumakiri et al18 demonstrated ultrastructural damage to dermal nerve fibers following UVA irradiation. UV radiation has been shown to cause a sensitizing effect on sensory nerve fibers and lower the threshold for sensory nerve stimulation, which may occur via direct effects of UV exposure or by release of neural mediators.19 The pathophysiology of brachioradial pruritus is controversial. The 2 proposed associations are UV exposure and cervical spine disease.20 Wallengren and Sundler2 proposed that solar-induced nerve injury is responsible for brachioradial pruritus. UV radiation may be an eliciting factor, while cervical spine disease may be a predisposing factor.2 On the contrary, Fisher21 reported on the association of cervical nerve root impingement and involvement of 1 or more of the C5 to C8 cervical nerve root segments. Brachioradial pruritus has been reported in association with an ependymoma and secondary to cervical nerve compression.9,22 In a report by Heyl,9 4 of 14 patients demonstrated evidence of degenerative changes and osteoarthritis between C4 and C7. In addition, Heyl9 noted that brachioradial pruritus may be caused by compression of structures not identified by cervical radiographs. In a series of 11 patients with brachioradial pruritus who underwent radiography of the spine, Goodkin et al12 found that all patients demonstrated radiographic abnormalities of the cervical spine. Magnetic resonance imaging is the most reliable diagnostic method for cervical nerve root compression.20,22 Recently, Crevits20 suggested that neural damage from peripheral nerves by solar radiation or local injury or from central sensory pathways, such as cervical spine disease, is a nonspecific cause. In view of the literature, a definitive pathophysiology for brachioradial pruritus does not exist. It is clear that it is a unique clinical entity, but the pathophysiologic basis is not known. While the association between cervical spine disease and brachioradial pruritus is not fully understood, the prevalence of cervical spine disease is higher in patients with brachioradial pruritus.12 It has not been determined if this association is causal or causative.20 A similar localized itch syndrome, notalgia paresthetica (NP), also has been examined with respect to cervical spine pathology.12,23-25 NP is similar to brachioradial pruritus but involves the dorsal spinal nerves. Savk et al23 found the presence of vertebral column pathology in 7 of 10 patients with NP. A subsequent larger study involving 43 patients with NP reported that in 34 patients (79%), spinal pathology had been detected by radiographs. Additionally, in 65% of patients (28/43), changes were most prominent in the vertebrae and corresponded to clinically involved dermatomes.24 However, not all pathologies are detectable via radiographic imaging.25 Thus, Savk and Savk25 reinforced the necessity of clinical and radiographic examination. Histologic examination is not necessary for the clinical diagnosis of brachioradial pruritus. Cutaneous biopsies most often demonstrate nonspecific findings and/or chronic solar damage. Wallengren and Sundler2 compared cutaneous biopsies in afflicted and control patients utilizing antibodies against a pan-neuronal marker, protein gene product 9.5, calcitonin gene-related peptide, and vanilloid receptor subtype 1 (VR1) for capsaicin-sensitive nerve structures. The number of protein gene product 9.5 immunoreative nerve fibers was reduced in pruritic skin by 23% to 43%.2 These findings suggest that brachioradial pruritus may be elicited by exposure to UV radiation and/or heat. Wallengren and Sundler2 noted one patient who relapsed with pruritus during the winter following use of a heating pad to relieve neck pain, which supports the notion that UV radiation and/or heat may be causative. Immunohistochemical studies demonstrated protein gene product 9.5 immunoreactive nerve fibers in a dense population in the epidermis and the dermis and calcitonin gene-related peptide immunoreactive nerve fibers located primarily in the dermis. Capsaicin-sensitive VR1 immunoreactive nerve fibers were located as free nerve fibers.2 Wallengren and Sundler2 proposed that the VR1 structures are associated with thermoreception. The reduction in nerve fibers via all markers in patients with brachioradial pruritus implicates their role. Furthermore, these histologic changes resemble those found in patients after serial phototherapy.2,26 Underlying cervical spine disease may amplify this pruritus. Treatment of brachioradial pruritus includes a multitude of possible topical and oral modalities, such as topical capsaicin, gabapentin, carbamazepine, oxcarbamazepine, cervical spine manipulation, anti-inflammatory medications, surgical rib resection, avoidance of sun exposure, and lamotrigine.1,3,5,12,20,21,27-32 Pruritus is a common symptom with a multitude of potential causes, some of which are never diagnosed. The absence of cutaneous signs makes diagnosis more difficult; however, the consistency of anatomic location and historical characteristics make the diagnosis of brachioradial pruritus possible. In addition, relief of pruritus with application of ice helps to confirm the diagnosis.10 A familial form of brachioradial pruritus was reported with a dominant and possible X-linked inheritance pattern.33 While an association between brachioradial pruritus and cervical spine disease is present, cervical spine disease alone cannot explain the pathophysiology of brachioradial pruritus. Furthermore, cervical spine disease undetectable by radiography may hinder a definitive understanding of this association. It is likely that both UV exposure and cervical spine disease contribute to this entity.

References

  1. Veien NK, Hattel T, Laurberg G, et al. Brachioradial pruritus. J Am Acad Dermatol. 2001;44:704-705.
  2. Wallengren J, Sundler F. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during symptom-free remissions. J Am Acad Dermatol. 2005;52:142-145.
  3. Barry R, Rogers S. Brachioradial pruritus—an enigmatic entity. Clin Exp Dermatol. 2004;29:637-638.
  4. Cohen AD, Masalha R, Medvedovsky E, et al. Brachioradial pruritus: a symptom of neuropathy. J Am Acad Dermatol. 2003;48:825-828.
  5. Wallengren J. Brachioradial pruritus: a recurrent solar dermopathy. J Am Acad Dermatol. 1998;39(5, pt 1):803-806
  6. Waisman M. Solar pruritus of the elbows (brachioradial summer pruritus). Arch Dermatol. 1968;98:481-485.
  7. Knight TE, Hayashi T. Solar (brachioradial) pruritus—response to capsaicin cream. Int J Dermatol. 1994;33:206-209.
  8. Walcyk PJ, Elpern DJ. Brachioradial pruritus: a tropical dermopathy. Br J Dermatol. 1986;115:177-180.
  9. Heyl T. Brachioradial pruritus. Arch Dermatol. 1983;119:115-116.
  10. Bernhard JD, Bordeaux JS. Medical pearl: the ice-pack sign in brachioradial pruritus. J Am Acad Dermatol. 2005;52:1073.
  11. Gilchrest BA, Soter NA, Hawk JL, et al. Histologic changes associated with ultraviolet A–induced erythema in normal human skin. J Am Acad Dermatol. 1983;9:213-219.
  12. Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic pruritus. J Am Acad Dermatol. 2003;48:521-524.
  13. Fruhstorfer H, Hermanns M, Latzke L. The effects of thermal stimulation on clinical and experimental itch. Pain. 1986;24:259-269.
  14. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96:7-26.
  15. Wallengren J. The pathophysiology of itch. Eur J Dermatol. 1993;3:643-647.
  16. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
  17. Teofoli P, Procacci P, Maresca M, et al. Itch and pain. Int J Dermatol. 1996;35:159-166.
  18. Kumakiri M, Hashimoto K, Willis I. Biological changes of human cutaneous nerves caused by ultraviolet irradiation: an ultrastructural study. Br J Dermatol. 1978;99:65-75.
  19. Legat FJ, Wolf P. Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin? Photochem Photobiol Sci. 2006;5:170-176.
  20. Crevits L. Brachioradial pruritus—a peculiar neuropathic disorder. Clin Neurol Neurosurg. 2006;108:803-805.
  21. Fisher DA. Brachioradial pruritus wanted: a sure cause (and cure) for brachioradial pruritus. Int J Dermatol. 1997;36:817-818.
  22. Kavak A, Dosoglu M. Can a spinal cord tumor cause brachioradial pruritus? J Am Acad Dermatol. 2002;46:437-440.
  23. Savk E, Savk O, Bolukbasi O, et al. Notalgia paresthetica: a study on pathogenesis. Int J Dermatol. 2000;39:754-759.
  24. Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol. 2005;52:1085-1087.
  25. Savk E, Savk SO. On brachioradial pruritus and notalgia paresthetica. J Am Acad Dermatol. 20
References

  1. Veien NK, Hattel T, Laurberg G, et al. Brachioradial pruritus. J Am Acad Dermatol. 2001;44:704-705.
  2. Wallengren J, Sundler F. Brachioradial pruritus is associated with a reduction in cutaneous innervation that normalizes during symptom-free remissions. J Am Acad Dermatol. 2005;52:142-145.
  3. Barry R, Rogers S. Brachioradial pruritus—an enigmatic entity. Clin Exp Dermatol. 2004;29:637-638.
  4. Cohen AD, Masalha R, Medvedovsky E, et al. Brachioradial pruritus: a symptom of neuropathy. J Am Acad Dermatol. 2003;48:825-828.
  5. Wallengren J. Brachioradial pruritus: a recurrent solar dermopathy. J Am Acad Dermatol. 1998;39(5, pt 1):803-806
  6. Waisman M. Solar pruritus of the elbows (brachioradial summer pruritus). Arch Dermatol. 1968;98:481-485.
  7. Knight TE, Hayashi T. Solar (brachioradial) pruritus—response to capsaicin cream. Int J Dermatol. 1994;33:206-209.
  8. Walcyk PJ, Elpern DJ. Brachioradial pruritus: a tropical dermopathy. Br J Dermatol. 1986;115:177-180.
  9. Heyl T. Brachioradial pruritus. Arch Dermatol. 1983;119:115-116.
  10. Bernhard JD, Bordeaux JS. Medical pearl: the ice-pack sign in brachioradial pruritus. J Am Acad Dermatol. 2005;52:1073.
  11. Gilchrest BA, Soter NA, Hawk JL, et al. Histologic changes associated with ultraviolet A–induced erythema in normal human skin. J Am Acad Dermatol. 1983;9:213-219.
  12. Goodkin R, Wingard E, Bernhard JD. Brachioradial pruritus: cervical spine disease and neurogenic/neuropathic pruritus. J Am Acad Dermatol. 2003;48:521-524.
  13. Fruhstorfer H, Hermanns M, Latzke L. The effects of thermal stimulation on clinical and experimental itch. Pain. 1986;24:259-269.
  14. Twycross R, Greaves MW, Handwerker H, et al. Itch: scratching more than the surface. QJM. 2003;96:7-26.
  15. Wallengren J. The pathophysiology of itch. Eur J Dermatol. 1993;3:643-647.
  16. Melzack R, Wall PD. Pain mechanisms: a new theory. Science. 1965;150:971-979.
  17. Teofoli P, Procacci P, Maresca M, et al. Itch and pain. Int J Dermatol. 1996;35:159-166.
  18. Kumakiri M, Hashimoto K, Willis I. Biological changes of human cutaneous nerves caused by ultraviolet irradiation: an ultrastructural study. Br J Dermatol. 1978;99:65-75.
  19. Legat FJ, Wolf P. Photodamage to the cutaneous sensory nerves: role in photoaging and carcinogenesis of the skin? Photochem Photobiol Sci. 2006;5:170-176.
  20. Crevits L. Brachioradial pruritus—a peculiar neuropathic disorder. Clin Neurol Neurosurg. 2006;108:803-805.
  21. Fisher DA. Brachioradial pruritus wanted: a sure cause (and cure) for brachioradial pruritus. Int J Dermatol. 1997;36:817-818.
  22. Kavak A, Dosoglu M. Can a spinal cord tumor cause brachioradial pruritus? J Am Acad Dermatol. 2002;46:437-440.
  23. Savk E, Savk O, Bolukbasi O, et al. Notalgia paresthetica: a study on pathogenesis. Int J Dermatol. 2000;39:754-759.
  24. Savk O, Savk E. Investigation of spinal pathology in notalgia paresthetica. J Am Acad Dermatol. 2005;52:1085-1087.
  25. Savk E, Savk SO. On brachioradial pruritus and notalgia paresthetica. J Am Acad Dermatol. 20
Issue
Cutis - 81(1)
Issue
Cutis - 81(1)
Page Number
37-40
Page Number
37-40
Publications
Publications
Topics
Article Type
Display Headline
Brachioradial Pruritus: A Case Report and Review of the Literature
Display Headline
Brachioradial Pruritus: A Case Report and Review of the Literature
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Childhood Dermatitis Herpetiformis: A Case Report and Review of the Literature

Article Type
Changed
Thu, 01/10/2019 - 12:12
Display Headline
Childhood Dermatitis Herpetiformis: A Case Report and Review of the Literature

Dermatitis herpetiformis (DH) is a chronic pruritic cutaneous eruption associated with gluten-sensitive enteropathy (celiac disease [CD]) and immunoglobulin A (IgA) deposition in the skin. While the disease is not uncommon among adolescents, DH is rarely seen in prepubertal patients. Children with DH present similarly to adults; however, uncommon skin findings have been reported. Because of an increased risk for autoimmune diseases and lymphoma, accurate diagnosis and treatment are imperative. We present a case of DH in a 6-year-old Latino boy previously diagnosed with atopic dermatitis and recurrent urticaria. Our aim is to highlight the various cutaneous presentations of DH and encourage clinicians to consider this diagnosis in young patients with recalcitrant atypical skin disease.
Case Report
A 6-year-old Latino boy presented with a history of pruritic skin lesions (beginning at the age of 9 months) previously diagnosed as atopic dermatitis and recurrent urticaria. His pediatrician prescribed topical steroids and oral diphenhydramine hydrochloride, without improvement. On examination, the patient had few excoriated edematous papules on his buttocks (Figure 1) and urticarial plaques on his upper extremity. His skin was xerotic but lacked any lichenified plaques or papules in the antecubital and popliteal fossae. The patient denied any associated nausea or diarrhea. Family history was negative for atopy and autoimmune disease. The mother reported that the patient was, at one time, "small for his age" but is now closer in size to his peers.

A punch biopsy was obtained from an urticarial plaque on his arm and treatment was initiated with desonide cream 0.05% twice daily to the affected areas. The biopsy revealed collections of neutrophils in the papillary dermis as well as clefting at the dermoepidermal junction (Figure 2). A second biopsy for direct immunofluorescence (DIF) was performed from perilesional gluteal skin. This specimen exhibited granular immunoglobulin A (IgA) deposits in the papillary dermis, thus confirming the diagnosis of dermatitis herpetiformis (DH).

Evaluation by a gastroenterologist who performed serologic testing and endoscopic biopsy of the small intestine further substantiated the diagnosis. In the serum, the presence of immunoglobulin G antigliadin (42.3 U/mL; reference, 100 U/mL; reference, <10), IgA anti–tissue transglutaminase (anti-tTGase)(>100 U/mL; reference, <4), and IgA antiendomysial (positive; reference, negative) antibodies were detected. The intestinal biopsy revealed villous atrophy accompanied by duodenitis consistent with celiac disease (CD). HLA typing was not performed. A complete blood count with differential blood count, comprehensive metabolic panel, thyroxine, thyroid stimulating hormone, and thyroglobulin antibodies were all within reference range. The patient was initiated on a gluten-free diet and subsequently developed fewer lesions and reduced pruritus.

Comment

DH is a cutaneous manifestation of CD, which is an immune-mediated enteropathy caused by gluten sensitivity. The symptoms of childhood CD include persistent diarrhea, failure to thrive, abdominal pain, and vomiting. Iron deficiency anemia also may be present as well as other sequelae of malabsorption. Although patients with DH usually do not have gastrointestinal symptoms, virtually all patients with DH show evidence of the same gluten-sensitive enteropathy of the small bowel.
Gluten is a grain protein found in wheat, barley, and rye, but not in oats. Gliadin, the alcohol-soluble fraction of gluten, is believed to be the inciting stimulus.1 In addition to antigliadin antibodies, patients with DH have circulating antiendomysial and antitransglutaminase antibodies with uncertain roles in pathogenesis. The prevailing theory suggests that gluten sensitivity leads to the formation of IgA antibodies to gluten-transglutaminase complexes. These antibodies cross-react with other transglutaminases, specifically epidermal transglutaminase, which is highly homologous. Deposition of IgA–transglutaminase 3 complexes within the papillary dermis cause skin lesions of DH.2,3
Childhood DH is rare, with an uncertain incidence and prevalence. Cases have been reported in children as young as 8 months,4 but most children receive the diagnosis between the ages of 2 and 7 years.5 DH is most prevalent in individuals of Northern European descent. In adults, men with DH outnumber women by a ratio of nearly 2:16; however, among childhood cases, there is a female predominance.5,7 A genetic predisposition for gluten sensitivity is supported by the high prevalence of DH and CD among first-degree relatives of known patients with DH and CD as well as a documented HLA association. The DQ2 and DQ8 alleles are most closely linked with DH and CD.8
The clinical presentation of DH is characterized by symmetrically distributed papulovesicular lesions and urticarial plaques, often favoring the back, buttocks, and extensor surfaces of the extremities. Because the lesions are intensely pruritic, intact vesicles are rarely observed by the clinician. Children, by most accounts, present similarly to adults; however, uncommon skin findings may be present and include isolated involvement of the palms,9 hemorrhagic lesions of the palms and soles,10 deep dermal papules and nodules,11 and facial lesions.5,11 Powell et al12 described a case with a predominance of urticarial lesions. Thus, childhood DH often is misdiagnosed as atopic dermatitis, papular urticaria, scabies, linear IgA dermatosis, or chronic urticaria. Recalcitrant cases of these diseases or patients who present with atypical findings of common diseases like atopic dermatitis should prompt the clinician to consider DH in the differential diagnosis.
The gold standard for diagnosing DH is DIF of a biopsy from perilesional skin, which shows granular IgA deposits most often localized to the papillary dermis. For routine histology, a biopsy of an intact vesicle is preferred where neutrophils in the papillary dermis and clefting at the dermoepidermal junction are seen. Although granular IgA deposits seen on DIF are highly specific for DH, up to 10% of cases may have a negative DIF.13,14 To confirm the diagnosis, serologic testing for anti-tTGase antibodies is useful. Using an enzyme-linked immunosorbent assay, tTGase antibodies can be detected in serum with specificity and sensitivity above 90% for patients on normal diets.15,16 Desai et al17 documented the cost-effectiveness of enzyme-linked immunosorbent assay tTGase testing and proposed that serologic testing be used primarily in the diagnosis of DH. Once patients remove gluten from their diet, the skin lesions and enteropathy resolve. Furthermore, tTGase antibodies decrease to levels within reference range in the absence of gluten; thus, serologic testing can be used to monitor dietary compliance.
Patients with DH are at higher risk for autoimmune diseases, particularly Hashimoto thyroiditis, pernicious anemia, and type 1 diabetes mellitus, among others.18-20 The association between DH and lymphoma, mostly T-cell lymphoma, is well-documented, with 78% of lymphomas arising from the small bowel, thus warranting vigilant surveillance and regular follow-up with a gastroenterologist.21 Lewis et al,22 in a retrospective study of 487 patients with DH, found that lymphoma only occurred in patients not on gluten-free diets or in patients who had followed the gluten-free diet for less than 5 years. Moreover, patients in this study who did adhere to the gluten-free diet had no increased risk for developing lymphoma over the general population.22
The primary treatment of DH is a gluten-free diet that is protective against the development of lymphoma. Dietary compliance is challenging, especially for children; therefore, referral to a dietician familiar with this area is helpful. Because months of dietary restriction are needed before a response is noted, many patients require pharmacologic treatment with dapsone. The recommended starting dose for children is 2 mg/kg daily with titration based on clinical response.23 Most patients will have a rapid response to dapsone within 48 to 72 hours. However, the enteropathy is unaffected by dapsone therapy and patients should be encouraged to maintain dietary compliance.

 

 

Conclusion

Childhood DH is rare and can present with atypical lesions involving the palms and soles, urticarial lesions, deep dermal papules and nodules, and facial lesions. If aware of these unusual presentations, clinicians may consider the diagnosis of DH and act to further evaluate cases of suspected common diseases not responding to treatment.

References

  1. Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterol. 1998;155:206-210.
  2. Preisz K, Sárdy M, Horváth A, et al. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2005;19:74-79.
  3. Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci. 2004;34:83-90.
  4. Lemberg D, Day AS, Bohane T. Coeliac disease presenting as dermatitis herpetiformis in infancy. J Paediatr Child Health. 2005;41:294-296.
  5. Ermacora E, Prampolini L, Tribbia G, et al. Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol. 1986;15:24-30.
  6. Bardella MT, Fredella C, Saladino V, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005;40:15-19.
  7. Reunala T, Lokki J. Dermatitis herpetiformis in Finland. Acta Derm Venereol. 1978;58:505-510.
  8. Reunala T. Incidence of familial dermatitis herpetiformis. Br J Dermatol. 1996;134:394-398.
  9. McGovern T, Bennion S. Palmar purpura: an atypical presentation of childhood dermatitis herpetiformis. Pediatr Dermatol. 1994;11:319-322.
  10. Karpati S, Torok E, Kosnai I. Discrete palmar and plantar symptoms in children with dermatitis herpetiformis Duhring. Cutis. 1986;37:184-187.
  11. Woolans A, Darley C, Bohgal B, et al. Childhood dermatitis herpetiformis: an unusual presentation. Clin Exp Dermatol. 1999;24:283-285.
  12. Powell GR, Bruckner AL, Weston WL. Dermatitis herpetiformis presenting as chronic urticaria. Pediatr Dermatol. 2004;21:564-567.
  13. Sousa L, Bajanca R, Cabral J, et al. Dermatitis herpetiformis: should direct immunofluorescence be the only diagnostic criterion? Pediatr Dermatol. 2002;19:336-339.
  14. Beutner EH, Baughman RD, Austin BM, et al. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescence findings. J Am Acad Dermatol. 2000;43:329-332.
  15. Caproni M, Cardinali C, Renzi D, et al. Tissue transglutaminase antibody assessment in dermatitis herpetiformis. Br J Dermatol. 2001;144:196-197.
  16. Dieterich W, Laag E, Bruckner-Tuderman L, et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999;113:133-136.
  17. Desai AM, Krishnan RS, Hsu S. Medical pearl: using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis. J Am Acad Dermatol. 2005;53:867-868.
  18. Reijonen H, Ilonen J, Knip M, et al. Insulin dependent diabetes mellitus associated with dermatitis herpetiformis: evidence for heterogeneity of HLA-associated genes. Tissue Antigens. 1991;37:94-96.
  19. Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis. prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med. 1985;102:194-196.
  20. Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9: 347-360.
  21. Bose SK, Lacour JP, Bodokh I, et al. Malignant lymphoma and dermatitis herpetiformis. Dermatology. 1994;188:
Article PDF
Author and Disclosure Information

Drs. Templet, Welsh, and Cusack report no conflict of interest. The authors report no discussion of off-label use. Dr. Templet is a dermatologist, Center for Sight, Sarasota, Florida. Dr. Welsh is a dermatologist, Division of Dermatology, Western Pennsylvania Hospital, Pittsburgh. Dr. Cusack is Assistant Professor, Drexel University College of Medicine, Philadelphia, Pennsylvania.

Julie T. Templet, MD; John Patrick Welsh, MD; Carrie Ann Cusack, MD

Issue
Cutis - 80(6)
Publications
Topics
Page Number
473-476
Author and Disclosure Information

Drs. Templet, Welsh, and Cusack report no conflict of interest. The authors report no discussion of off-label use. Dr. Templet is a dermatologist, Center for Sight, Sarasota, Florida. Dr. Welsh is a dermatologist, Division of Dermatology, Western Pennsylvania Hospital, Pittsburgh. Dr. Cusack is Assistant Professor, Drexel University College of Medicine, Philadelphia, Pennsylvania.

Julie T. Templet, MD; John Patrick Welsh, MD; Carrie Ann Cusack, MD

Author and Disclosure Information

Drs. Templet, Welsh, and Cusack report no conflict of interest. The authors report no discussion of off-label use. Dr. Templet is a dermatologist, Center for Sight, Sarasota, Florida. Dr. Welsh is a dermatologist, Division of Dermatology, Western Pennsylvania Hospital, Pittsburgh. Dr. Cusack is Assistant Professor, Drexel University College of Medicine, Philadelphia, Pennsylvania.

Julie T. Templet, MD; John Patrick Welsh, MD; Carrie Ann Cusack, MD

Article PDF
Article PDF

Dermatitis herpetiformis (DH) is a chronic pruritic cutaneous eruption associated with gluten-sensitive enteropathy (celiac disease [CD]) and immunoglobulin A (IgA) deposition in the skin. While the disease is not uncommon among adolescents, DH is rarely seen in prepubertal patients. Children with DH present similarly to adults; however, uncommon skin findings have been reported. Because of an increased risk for autoimmune diseases and lymphoma, accurate diagnosis and treatment are imperative. We present a case of DH in a 6-year-old Latino boy previously diagnosed with atopic dermatitis and recurrent urticaria. Our aim is to highlight the various cutaneous presentations of DH and encourage clinicians to consider this diagnosis in young patients with recalcitrant atypical skin disease.
Case Report
A 6-year-old Latino boy presented with a history of pruritic skin lesions (beginning at the age of 9 months) previously diagnosed as atopic dermatitis and recurrent urticaria. His pediatrician prescribed topical steroids and oral diphenhydramine hydrochloride, without improvement. On examination, the patient had few excoriated edematous papules on his buttocks (Figure 1) and urticarial plaques on his upper extremity. His skin was xerotic but lacked any lichenified plaques or papules in the antecubital and popliteal fossae. The patient denied any associated nausea or diarrhea. Family history was negative for atopy and autoimmune disease. The mother reported that the patient was, at one time, "small for his age" but is now closer in size to his peers.

A punch biopsy was obtained from an urticarial plaque on his arm and treatment was initiated with desonide cream 0.05% twice daily to the affected areas. The biopsy revealed collections of neutrophils in the papillary dermis as well as clefting at the dermoepidermal junction (Figure 2). A second biopsy for direct immunofluorescence (DIF) was performed from perilesional gluteal skin. This specimen exhibited granular immunoglobulin A (IgA) deposits in the papillary dermis, thus confirming the diagnosis of dermatitis herpetiformis (DH).

Evaluation by a gastroenterologist who performed serologic testing and endoscopic biopsy of the small intestine further substantiated the diagnosis. In the serum, the presence of immunoglobulin G antigliadin (42.3 U/mL; reference, 100 U/mL; reference, <10), IgA anti–tissue transglutaminase (anti-tTGase)(>100 U/mL; reference, <4), and IgA antiendomysial (positive; reference, negative) antibodies were detected. The intestinal biopsy revealed villous atrophy accompanied by duodenitis consistent with celiac disease (CD). HLA typing was not performed. A complete blood count with differential blood count, comprehensive metabolic panel, thyroxine, thyroid stimulating hormone, and thyroglobulin antibodies were all within reference range. The patient was initiated on a gluten-free diet and subsequently developed fewer lesions and reduced pruritus.

Comment

DH is a cutaneous manifestation of CD, which is an immune-mediated enteropathy caused by gluten sensitivity. The symptoms of childhood CD include persistent diarrhea, failure to thrive, abdominal pain, and vomiting. Iron deficiency anemia also may be present as well as other sequelae of malabsorption. Although patients with DH usually do not have gastrointestinal symptoms, virtually all patients with DH show evidence of the same gluten-sensitive enteropathy of the small bowel.
Gluten is a grain protein found in wheat, barley, and rye, but not in oats. Gliadin, the alcohol-soluble fraction of gluten, is believed to be the inciting stimulus.1 In addition to antigliadin antibodies, patients with DH have circulating antiendomysial and antitransglutaminase antibodies with uncertain roles in pathogenesis. The prevailing theory suggests that gluten sensitivity leads to the formation of IgA antibodies to gluten-transglutaminase complexes. These antibodies cross-react with other transglutaminases, specifically epidermal transglutaminase, which is highly homologous. Deposition of IgA–transglutaminase 3 complexes within the papillary dermis cause skin lesions of DH.2,3
Childhood DH is rare, with an uncertain incidence and prevalence. Cases have been reported in children as young as 8 months,4 but most children receive the diagnosis between the ages of 2 and 7 years.5 DH is most prevalent in individuals of Northern European descent. In adults, men with DH outnumber women by a ratio of nearly 2:16; however, among childhood cases, there is a female predominance.5,7 A genetic predisposition for gluten sensitivity is supported by the high prevalence of DH and CD among first-degree relatives of known patients with DH and CD as well as a documented HLA association. The DQ2 and DQ8 alleles are most closely linked with DH and CD.8
The clinical presentation of DH is characterized by symmetrically distributed papulovesicular lesions and urticarial plaques, often favoring the back, buttocks, and extensor surfaces of the extremities. Because the lesions are intensely pruritic, intact vesicles are rarely observed by the clinician. Children, by most accounts, present similarly to adults; however, uncommon skin findings may be present and include isolated involvement of the palms,9 hemorrhagic lesions of the palms and soles,10 deep dermal papules and nodules,11 and facial lesions.5,11 Powell et al12 described a case with a predominance of urticarial lesions. Thus, childhood DH often is misdiagnosed as atopic dermatitis, papular urticaria, scabies, linear IgA dermatosis, or chronic urticaria. Recalcitrant cases of these diseases or patients who present with atypical findings of common diseases like atopic dermatitis should prompt the clinician to consider DH in the differential diagnosis.
The gold standard for diagnosing DH is DIF of a biopsy from perilesional skin, which shows granular IgA deposits most often localized to the papillary dermis. For routine histology, a biopsy of an intact vesicle is preferred where neutrophils in the papillary dermis and clefting at the dermoepidermal junction are seen. Although granular IgA deposits seen on DIF are highly specific for DH, up to 10% of cases may have a negative DIF.13,14 To confirm the diagnosis, serologic testing for anti-tTGase antibodies is useful. Using an enzyme-linked immunosorbent assay, tTGase antibodies can be detected in serum with specificity and sensitivity above 90% for patients on normal diets.15,16 Desai et al17 documented the cost-effectiveness of enzyme-linked immunosorbent assay tTGase testing and proposed that serologic testing be used primarily in the diagnosis of DH. Once patients remove gluten from their diet, the skin lesions and enteropathy resolve. Furthermore, tTGase antibodies decrease to levels within reference range in the absence of gluten; thus, serologic testing can be used to monitor dietary compliance.
Patients with DH are at higher risk for autoimmune diseases, particularly Hashimoto thyroiditis, pernicious anemia, and type 1 diabetes mellitus, among others.18-20 The association between DH and lymphoma, mostly T-cell lymphoma, is well-documented, with 78% of lymphomas arising from the small bowel, thus warranting vigilant surveillance and regular follow-up with a gastroenterologist.21 Lewis et al,22 in a retrospective study of 487 patients with DH, found that lymphoma only occurred in patients not on gluten-free diets or in patients who had followed the gluten-free diet for less than 5 years. Moreover, patients in this study who did adhere to the gluten-free diet had no increased risk for developing lymphoma over the general population.22
The primary treatment of DH is a gluten-free diet that is protective against the development of lymphoma. Dietary compliance is challenging, especially for children; therefore, referral to a dietician familiar with this area is helpful. Because months of dietary restriction are needed before a response is noted, many patients require pharmacologic treatment with dapsone. The recommended starting dose for children is 2 mg/kg daily with titration based on clinical response.23 Most patients will have a rapid response to dapsone within 48 to 72 hours. However, the enteropathy is unaffected by dapsone therapy and patients should be encouraged to maintain dietary compliance.

 

 

Conclusion

Childhood DH is rare and can present with atypical lesions involving the palms and soles, urticarial lesions, deep dermal papules and nodules, and facial lesions. If aware of these unusual presentations, clinicians may consider the diagnosis of DH and act to further evaluate cases of suspected common diseases not responding to treatment.

Dermatitis herpetiformis (DH) is a chronic pruritic cutaneous eruption associated with gluten-sensitive enteropathy (celiac disease [CD]) and immunoglobulin A (IgA) deposition in the skin. While the disease is not uncommon among adolescents, DH is rarely seen in prepubertal patients. Children with DH present similarly to adults; however, uncommon skin findings have been reported. Because of an increased risk for autoimmune diseases and lymphoma, accurate diagnosis and treatment are imperative. We present a case of DH in a 6-year-old Latino boy previously diagnosed with atopic dermatitis and recurrent urticaria. Our aim is to highlight the various cutaneous presentations of DH and encourage clinicians to consider this diagnosis in young patients with recalcitrant atypical skin disease.
Case Report
A 6-year-old Latino boy presented with a history of pruritic skin lesions (beginning at the age of 9 months) previously diagnosed as atopic dermatitis and recurrent urticaria. His pediatrician prescribed topical steroids and oral diphenhydramine hydrochloride, without improvement. On examination, the patient had few excoriated edematous papules on his buttocks (Figure 1) and urticarial plaques on his upper extremity. His skin was xerotic but lacked any lichenified plaques or papules in the antecubital and popliteal fossae. The patient denied any associated nausea or diarrhea. Family history was negative for atopy and autoimmune disease. The mother reported that the patient was, at one time, "small for his age" but is now closer in size to his peers.

A punch biopsy was obtained from an urticarial plaque on his arm and treatment was initiated with desonide cream 0.05% twice daily to the affected areas. The biopsy revealed collections of neutrophils in the papillary dermis as well as clefting at the dermoepidermal junction (Figure 2). A second biopsy for direct immunofluorescence (DIF) was performed from perilesional gluteal skin. This specimen exhibited granular immunoglobulin A (IgA) deposits in the papillary dermis, thus confirming the diagnosis of dermatitis herpetiformis (DH).

Evaluation by a gastroenterologist who performed serologic testing and endoscopic biopsy of the small intestine further substantiated the diagnosis. In the serum, the presence of immunoglobulin G antigliadin (42.3 U/mL; reference, 100 U/mL; reference, <10), IgA anti–tissue transglutaminase (anti-tTGase)(>100 U/mL; reference, <4), and IgA antiendomysial (positive; reference, negative) antibodies were detected. The intestinal biopsy revealed villous atrophy accompanied by duodenitis consistent with celiac disease (CD). HLA typing was not performed. A complete blood count with differential blood count, comprehensive metabolic panel, thyroxine, thyroid stimulating hormone, and thyroglobulin antibodies were all within reference range. The patient was initiated on a gluten-free diet and subsequently developed fewer lesions and reduced pruritus.

Comment

DH is a cutaneous manifestation of CD, which is an immune-mediated enteropathy caused by gluten sensitivity. The symptoms of childhood CD include persistent diarrhea, failure to thrive, abdominal pain, and vomiting. Iron deficiency anemia also may be present as well as other sequelae of malabsorption. Although patients with DH usually do not have gastrointestinal symptoms, virtually all patients with DH show evidence of the same gluten-sensitive enteropathy of the small bowel.
Gluten is a grain protein found in wheat, barley, and rye, but not in oats. Gliadin, the alcohol-soluble fraction of gluten, is believed to be the inciting stimulus.1 In addition to antigliadin antibodies, patients with DH have circulating antiendomysial and antitransglutaminase antibodies with uncertain roles in pathogenesis. The prevailing theory suggests that gluten sensitivity leads to the formation of IgA antibodies to gluten-transglutaminase complexes. These antibodies cross-react with other transglutaminases, specifically epidermal transglutaminase, which is highly homologous. Deposition of IgA–transglutaminase 3 complexes within the papillary dermis cause skin lesions of DH.2,3
Childhood DH is rare, with an uncertain incidence and prevalence. Cases have been reported in children as young as 8 months,4 but most children receive the diagnosis between the ages of 2 and 7 years.5 DH is most prevalent in individuals of Northern European descent. In adults, men with DH outnumber women by a ratio of nearly 2:16; however, among childhood cases, there is a female predominance.5,7 A genetic predisposition for gluten sensitivity is supported by the high prevalence of DH and CD among first-degree relatives of known patients with DH and CD as well as a documented HLA association. The DQ2 and DQ8 alleles are most closely linked with DH and CD.8
The clinical presentation of DH is characterized by symmetrically distributed papulovesicular lesions and urticarial plaques, often favoring the back, buttocks, and extensor surfaces of the extremities. Because the lesions are intensely pruritic, intact vesicles are rarely observed by the clinician. Children, by most accounts, present similarly to adults; however, uncommon skin findings may be present and include isolated involvement of the palms,9 hemorrhagic lesions of the palms and soles,10 deep dermal papules and nodules,11 and facial lesions.5,11 Powell et al12 described a case with a predominance of urticarial lesions. Thus, childhood DH often is misdiagnosed as atopic dermatitis, papular urticaria, scabies, linear IgA dermatosis, or chronic urticaria. Recalcitrant cases of these diseases or patients who present with atypical findings of common diseases like atopic dermatitis should prompt the clinician to consider DH in the differential diagnosis.
The gold standard for diagnosing DH is DIF of a biopsy from perilesional skin, which shows granular IgA deposits most often localized to the papillary dermis. For routine histology, a biopsy of an intact vesicle is preferred where neutrophils in the papillary dermis and clefting at the dermoepidermal junction are seen. Although granular IgA deposits seen on DIF are highly specific for DH, up to 10% of cases may have a negative DIF.13,14 To confirm the diagnosis, serologic testing for anti-tTGase antibodies is useful. Using an enzyme-linked immunosorbent assay, tTGase antibodies can be detected in serum with specificity and sensitivity above 90% for patients on normal diets.15,16 Desai et al17 documented the cost-effectiveness of enzyme-linked immunosorbent assay tTGase testing and proposed that serologic testing be used primarily in the diagnosis of DH. Once patients remove gluten from their diet, the skin lesions and enteropathy resolve. Furthermore, tTGase antibodies decrease to levels within reference range in the absence of gluten; thus, serologic testing can be used to monitor dietary compliance.
Patients with DH are at higher risk for autoimmune diseases, particularly Hashimoto thyroiditis, pernicious anemia, and type 1 diabetes mellitus, among others.18-20 The association between DH and lymphoma, mostly T-cell lymphoma, is well-documented, with 78% of lymphomas arising from the small bowel, thus warranting vigilant surveillance and regular follow-up with a gastroenterologist.21 Lewis et al,22 in a retrospective study of 487 patients with DH, found that lymphoma only occurred in patients not on gluten-free diets or in patients who had followed the gluten-free diet for less than 5 years. Moreover, patients in this study who did adhere to the gluten-free diet had no increased risk for developing lymphoma over the general population.22
The primary treatment of DH is a gluten-free diet that is protective against the development of lymphoma. Dietary compliance is challenging, especially for children; therefore, referral to a dietician familiar with this area is helpful. Because months of dietary restriction are needed before a response is noted, many patients require pharmacologic treatment with dapsone. The recommended starting dose for children is 2 mg/kg daily with titration based on clinical response.23 Most patients will have a rapid response to dapsone within 48 to 72 hours. However, the enteropathy is unaffected by dapsone therapy and patients should be encouraged to maintain dietary compliance.

 

 

Conclusion

Childhood DH is rare and can present with atypical lesions involving the palms and soles, urticarial lesions, deep dermal papules and nodules, and facial lesions. If aware of these unusual presentations, clinicians may consider the diagnosis of DH and act to further evaluate cases of suspected common diseases not responding to treatment.

References

  1. Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterol. 1998;155:206-210.
  2. Preisz K, Sárdy M, Horváth A, et al. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2005;19:74-79.
  3. Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci. 2004;34:83-90.
  4. Lemberg D, Day AS, Bohane T. Coeliac disease presenting as dermatitis herpetiformis in infancy. J Paediatr Child Health. 2005;41:294-296.
  5. Ermacora E, Prampolini L, Tribbia G, et al. Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol. 1986;15:24-30.
  6. Bardella MT, Fredella C, Saladino V, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005;40:15-19.
  7. Reunala T, Lokki J. Dermatitis herpetiformis in Finland. Acta Derm Venereol. 1978;58:505-510.
  8. Reunala T. Incidence of familial dermatitis herpetiformis. Br J Dermatol. 1996;134:394-398.
  9. McGovern T, Bennion S. Palmar purpura: an atypical presentation of childhood dermatitis herpetiformis. Pediatr Dermatol. 1994;11:319-322.
  10. Karpati S, Torok E, Kosnai I. Discrete palmar and plantar symptoms in children with dermatitis herpetiformis Duhring. Cutis. 1986;37:184-187.
  11. Woolans A, Darley C, Bohgal B, et al. Childhood dermatitis herpetiformis: an unusual presentation. Clin Exp Dermatol. 1999;24:283-285.
  12. Powell GR, Bruckner AL, Weston WL. Dermatitis herpetiformis presenting as chronic urticaria. Pediatr Dermatol. 2004;21:564-567.
  13. Sousa L, Bajanca R, Cabral J, et al. Dermatitis herpetiformis: should direct immunofluorescence be the only diagnostic criterion? Pediatr Dermatol. 2002;19:336-339.
  14. Beutner EH, Baughman RD, Austin BM, et al. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescence findings. J Am Acad Dermatol. 2000;43:329-332.
  15. Caproni M, Cardinali C, Renzi D, et al. Tissue transglutaminase antibody assessment in dermatitis herpetiformis. Br J Dermatol. 2001;144:196-197.
  16. Dieterich W, Laag E, Bruckner-Tuderman L, et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999;113:133-136.
  17. Desai AM, Krishnan RS, Hsu S. Medical pearl: using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis. J Am Acad Dermatol. 2005;53:867-868.
  18. Reijonen H, Ilonen J, Knip M, et al. Insulin dependent diabetes mellitus associated with dermatitis herpetiformis: evidence for heterogeneity of HLA-associated genes. Tissue Antigens. 1991;37:94-96.
  19. Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis. prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med. 1985;102:194-196.
  20. Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9: 347-360.
  21. Bose SK, Lacour JP, Bodokh I, et al. Malignant lymphoma and dermatitis herpetiformis. Dermatology. 1994;188:
References

  1. Godkin A, Jewell D. The pathogenesis of celiac disease. Gastroenterol. 1998;155:206-210.
  2. Preisz K, Sárdy M, Horváth A, et al. Immunoglobulin, complement and epidermal transglutaminase deposition in the cutaneous vessels in dermatitis herpetiformis. J Eur Acad Dermatol Venereol. 2005;19:74-79.
  3. Karpati S. Dermatitis herpetiformis: close to unravelling a disease. J Dermatol Sci. 2004;34:83-90.
  4. Lemberg D, Day AS, Bohane T. Coeliac disease presenting as dermatitis herpetiformis in infancy. J Paediatr Child Health. 2005;41:294-296.
  5. Ermacora E, Prampolini L, Tribbia G, et al. Long-term follow-up of dermatitis herpetiformis in children. J Am Acad Dermatol. 1986;15:24-30.
  6. Bardella MT, Fredella C, Saladino V, et al. Gluten intolerance: gender- and age-related differences in symptoms. Scand J Gastroenterol. 2005;40:15-19.
  7. Reunala T, Lokki J. Dermatitis herpetiformis in Finland. Acta Derm Venereol. 1978;58:505-510.
  8. Reunala T. Incidence of familial dermatitis herpetiformis. Br J Dermatol. 1996;134:394-398.
  9. McGovern T, Bennion S. Palmar purpura: an atypical presentation of childhood dermatitis herpetiformis. Pediatr Dermatol. 1994;11:319-322.
  10. Karpati S, Torok E, Kosnai I. Discrete palmar and plantar symptoms in children with dermatitis herpetiformis Duhring. Cutis. 1986;37:184-187.
  11. Woolans A, Darley C, Bohgal B, et al. Childhood dermatitis herpetiformis: an unusual presentation. Clin Exp Dermatol. 1999;24:283-285.
  12. Powell GR, Bruckner AL, Weston WL. Dermatitis herpetiformis presenting as chronic urticaria. Pediatr Dermatol. 2004;21:564-567.
  13. Sousa L, Bajanca R, Cabral J, et al. Dermatitis herpetiformis: should direct immunofluorescence be the only diagnostic criterion? Pediatr Dermatol. 2002;19:336-339.
  14. Beutner EH, Baughman RD, Austin BM, et al. A case of dermatitis herpetiformis with IgA endomysial antibodies but negative direct immunofluorescence findings. J Am Acad Dermatol. 2000;43:329-332.
  15. Caproni M, Cardinali C, Renzi D, et al. Tissue transglutaminase antibody assessment in dermatitis herpetiformis. Br J Dermatol. 2001;144:196-197.
  16. Dieterich W, Laag E, Bruckner-Tuderman L, et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol. 1999;113:133-136.
  17. Desai AM, Krishnan RS, Hsu S. Medical pearl: using tissue transglutaminase antibodies to diagnose dermatitis herpetiformis. J Am Acad Dermatol. 2005;53:867-868.
  18. Reijonen H, Ilonen J, Knip M, et al. Insulin dependent diabetes mellitus associated with dermatitis herpetiformis: evidence for heterogeneity of HLA-associated genes. Tissue Antigens. 1991;37:94-96.
  19. Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis. prevalence of clinical thyroid disease and thyroid autoantibodies. Ann Intern Med. 1985;102:194-196.
  20. Kaplan RP, Callen JP. Dermatitis herpetiformis: autoimmune disease associations. Clin Dermatol. 1991;9: 347-360.
  21. Bose SK, Lacour JP, Bodokh I, et al. Malignant lymphoma and dermatitis herpetiformis. Dermatology. 1994;188:
Issue
Cutis - 80(6)
Issue
Cutis - 80(6)
Page Number
473-476
Page Number
473-476
Publications
Publications
Topics
Article Type
Display Headline
Childhood Dermatitis Herpetiformis: A Case Report and Review of the Literature
Display Headline
Childhood Dermatitis Herpetiformis: A Case Report and Review of the Literature
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Topical Management of Superficial Fungal Infections: Focus on Sertaconazole

Article Type
Changed
Thu, 01/10/2019 - 12:41
Display Headline
Topical Management of Superficial Fungal Infections: Focus on Sertaconazole

Article PDF
Author and Disclosure Information

Del Rosso JQ, Bikowski J

Issue
Cutis - 80(5)
Publications
Topics
Page Number
705-710
Sections
Author and Disclosure Information

Del Rosso JQ, Bikowski J

Author and Disclosure Information

Del Rosso JQ, Bikowski J

Article PDF
Article PDF

Issue
Cutis - 80(5)
Issue
Cutis - 80(5)
Page Number
705-710
Page Number
705-710
Publications
Publications
Topics
Article Type
Display Headline
Topical Management of Superficial Fungal Infections: Focus on Sertaconazole
Display Headline
Topical Management of Superficial Fungal Infections: Focus on Sertaconazole
Sections
Article Source

Citation Override
Originally published in Cosmetic Dermatology
PURLs Copyright

Inside the Article

Article PDF Media

What's Eating You? Body Lice (Pediculus humanus var corporis)

Article Type
Changed
Thu, 01/10/2019 - 12:12
Display Headline
What's Eating You? Body Lice (Pediculus humanus var corporis)

Article PDF
Author and Disclosure Information

Mikhail M, Weinberg JM, Smith BL

Issue
Cutis - 80(5)
Publications
Topics
Page Number
397-398
Sections
Author and Disclosure Information

Mikhail M, Weinberg JM, Smith BL

Author and Disclosure Information

Mikhail M, Weinberg JM, Smith BL

Article PDF
Article PDF

Issue
Cutis - 80(5)
Issue
Cutis - 80(5)
Page Number
397-398
Page Number
397-398
Publications
Publications
Topics
Article Type
Display Headline
What's Eating You? Body Lice (Pediculus humanus var corporis)
Display Headline
What's Eating You? Body Lice (Pediculus humanus var corporis)
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

Common Dermatologic Disorders in Skin of Color: A Comparative Practice Survey

Article Type
Changed
Thu, 12/15/2022 - 15:12
Display Headline
Common Dermatologic Disorders in Skin of Color: A Comparative Practice Survey

Article PDF
Author and Disclosure Information

Alexis AF, Sergay AB, Taylor SC

Issue
Cutis - 80(5)
Publications
Topics
Page Number
387-394
Sections
Author and Disclosure Information

Alexis AF, Sergay AB, Taylor SC

Author and Disclosure Information

Alexis AF, Sergay AB, Taylor SC

Article PDF
Article PDF

Issue
Cutis - 80(5)
Issue
Cutis - 80(5)
Page Number
387-394
Page Number
387-394
Publications
Publications
Topics
Article Type
Display Headline
Common Dermatologic Disorders in Skin of Color: A Comparative Practice Survey
Display Headline
Common Dermatologic Disorders in Skin of Color: A Comparative Practice Survey
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media

The Role of Ketoconazole in Seborrheic Dermatitis

Article Type
Changed
Thu, 01/10/2019 - 12:12
Display Headline
The Role of Ketoconazole in Seborrheic Dermatitis

Article PDF
Author and Disclosure Information

Borgers M, Degreef H

Issue
Cutis - 80(4)
Publications
Topics
Page Number
359-363
Sections
Author and Disclosure Information

Borgers M, Degreef H

Author and Disclosure Information

Borgers M, Degreef H

Article PDF
Article PDF

Issue
Cutis - 80(4)
Issue
Cutis - 80(4)
Page Number
359-363
Page Number
359-363
Publications
Publications
Topics
Article Type
Display Headline
The Role of Ketoconazole in Seborrheic Dermatitis
Display Headline
The Role of Ketoconazole in Seborrheic Dermatitis
Sections
Article Source

PURLs Copyright

Inside the Article

Article PDF Media